{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:25:07Z","timestamp":1790486707922,"version":"4.1.0"},"reference-count":210,"publisher":"Elsevier","isbn-type":[{"value":"9780128022672","type":"print"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/bs.acc.2014.09.001","type":"book-chapter","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T21:33:37Z","timestamp":1415136817000},"page":"1-45","source":"Crossref","is-referenced-by-count":37,"title":["Biomarkers of Tobacco Smoke Exposure"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2014.09.001_bb0005","unstructured":"J. Borio, The Tobacco Timeline, Tobacco News and Information, Tobacco.org. http:\/\/archive.tobacco.org\/History\/Tobacco_history.html, 2010 (November 22, 2013)."},{"key":"10.1016\/bs.acc.2014.09.001_bb0010","series-title":"The Tobacco Atlas","author":"Eriksen","year":"2012"},{"key":"10.1016\/bs.acc.2014.09.001_bb0015","series-title":"A Counterblaste to Tobacco\u2014James I, Classical Utilitarianism","author":"Bonevac","year":"2002"},{"key":"10.1016\/bs.acc.2014.09.001_bb0020","first-page":"230","article-title":"Effects of tobacco on youths","volume":"7","author":"Gorgas","year":"1881","journal-title":"Public Health Pap. Rep."},{"key":"10.1016\/bs.acc.2014.09.001_bb0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2307\/4590516","article-title":"Tobacco consumption and mortality from cancer and other diseases","volume":"74","author":"Dorn","year":"1959","journal-title":"Public Health Rep."},{"key":"10.1016\/bs.acc.2014.09.001_bb0030","unstructured":"United States Department of Health and Human Services, Smoking and Health, United States. Public Health Service. Office of the Surgeon General, 1964."},{"key":"10.1016\/bs.acc.2014.09.001_bb0035","series-title":"The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General","author":"Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health","year":"2014"},{"key":"10.1016\/bs.acc.2014.09.001_bb0040","series-title":"WHO Report on the Global Tobacco Epidemic, 2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/bs.acc.2014.09.001_bb0045","series-title":"U.S. 111th Congress, Public Law 111\u201331: Family Smoking Prevention and Tobacco Control Act, H.R. 1256","year":"2009"},{"key":"10.1016\/bs.acc.2014.09.001_bb0050","unstructured":"U.S. FDA, Overview of the Family Smoking Prevention and Tobacco Control Act: Consumer fact Sheet, Tobacco Products: Guidance, Regulations & Compliance. <http:\/\/www.fda.gov\/TobaccoProducts\/GuidanceComplianceRegulatoryInformation\/ucm246129.htm>, 2013 (November 25, 2013)."},{"key":"10.1016\/bs.acc.2014.09.001_bb0055","unstructured":"U.S. FDA, Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act, Tobacco Products: Guidance, Regulations & Compliance. <http:\/\/www.fda.gov\/TobaccoProducts\/GuidanceComplianceRegulatoryInformation\/ucm297752.htm>, 2013 (November 25, 2013)."},{"key":"10.1016\/bs.acc.2014.09.001_bb0060","first-page":"13","article-title":"Do changes in cigarette design influence the rise in adenocarcinoma of the lung?","volume":"22","author":"Burns","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/bs.acc.2014.09.001_bb0065","series-title":"Biomarkers in Drug Development","first-page":"3","article-title":"Biomarkers are not new","author":"Dews","year":"2010"},{"key":"10.1016\/bs.acc.2014.09.001_bb0070","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jnci\/58.4.875","article-title":"Influence of renal insufficiency on levels of serum ribonuclease in patients with multiple myeloma","volume":"58","author":"Karpetsky","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.acc.2014.09.001_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/bs.acc.2014.09.001_bb0080","series-title":"Drug Development Tools Qualification Program\u2014Clinical Outcome Assessment Qualification Program","author":"U.S. FDA, Center for Drug Evaluation and Research","year":"2012"},{"key":"10.1016\/bs.acc.2014.09.001_bb0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2125.2012.04234.x","article-title":"Research priorities in biomarkers and surrogate end-points","volume":"73","author":"Aronson","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/pgmj.2008.073759","article-title":"How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease","volume":"85","author":"Puntmann","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/bs.acc.2014.09.001_bb0095","series-title":"Committee to Assess the Science Base for Tobacco Harm Reduction, Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction","author":"Stratton","year":"2001"},{"key":"10.1016\/bs.acc.2014.09.001_bb0100","first-page":"3","article-title":"Biological markers in environmental health research","volume":"74","author":"Committee on Biological Markers of the National Research Council","year":"1987","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/bs.acc.2014.09.001_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/bs.acc.2014.09.001_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MOL.0b013e32831551e0","article-title":"Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar","volume":"19","author":"Welsh","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0115","first-page":"37","article-title":"Metabolic biomarkers for predicting cardiovascular disease","volume":"9","author":"Montgomery","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/bs.acc.2014.09.001_bb0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2013.01.016","article-title":"Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes","volume":"227","author":"Fujisawa","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.acc.2014.09.001_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1378\/chest.07-1342","article-title":"Increased systemic inflammation is a risk factor for COPD exacerbations","volume":"133","author":"Groenewegen","year":"2008","journal-title":"Chest"},{"key":"10.1016\/bs.acc.2014.09.001_bb0130","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(05)66380-5","article-title":"Time and chance: the stochastic nature of disease causation","volume":"365","author":"Coggon","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2014.09.001_bb0135","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2010.02.019","article-title":"Multiple biomarkers for predicting cardiovascular events: lessons learned","volume":"55","author":"Wang","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/RES.0b013e31824da8ad","article-title":"Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease","volume":"110","author":"Ioannidis","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/1354750X.2010.533287","article-title":"Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption","volume":"16","author":"Minet","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/bs.acc.2014.09.001_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/toxsci\/kfq029","article-title":"Performance of novel kidney biomarkers in preclinical toxicity studies","volume":"116","author":"Hoffmann","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/bs.acc.2014.09.001_bb0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/14622200600576628","article-title":"Biomarkers to assess the utility of potential reduced exposure tobacco products","volume":"8","author":"Hatsukami","year":"2006","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11095-005-9045-3","article-title":"Fit-for-purpose method development and validation for successful biomarker measurement","volume":"23","author":"Lee","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1155\/2002\/212987","article-title":"Delivery of high-quality biomarker assays","volume":"18","author":"Swanson","year":"2002","journal-title":"Dis. Markers"},{"key":"10.1016\/bs.acc.2014.09.001_bb0170","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/CMR.00074-09","article-title":"Validation of laboratory-developed molecular assays for infectious diseases","volume":"23","author":"Burd","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0175","series-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","author":"Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health","year":"2010"},{"key":"10.1016\/bs.acc.2014.09.001_bb0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/tobaccocontrol-2011-050298","article-title":"Assessing secondhand smoke using biological markers","volume":"22","author":"Avila-Tang","year":"2013","journal-title":"Tob. Control."},{"key":"10.1016\/bs.acc.2014.09.001_bb0185","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/tx800479s","article-title":"Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers","volume":"22","author":"Carmella","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0190","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/tx100056m","article-title":"Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention","volume":"23","author":"Hecht","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0195","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ntr\/ntq235","article-title":"Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study","volume":"13","author":"Frost-Pineda","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0200","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/ntr\/ntp126","article-title":"Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers","volume":"11","author":"Roethig","year":"2009","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0205","series-title":"Population Assessment of Tobacco and Health (PATH)","author":"National Institutes of Health","year":"2014"},{"key":"10.1016\/bs.acc.2014.09.001_bb0210","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1194\/jlr.M700097-JLR200","article-title":"Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS\/MS","volume":"48","author":"Yan","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000105109.44620.1B","article-title":"Determinants of platelet activation in human essential hypertension","volume":"43","author":"Minuz","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/bs.acc.2014.09.001_bb0220","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1194\/jlr.D023739","article-title":"A simple and robust UPLC-SRM\/MS method to quantify urinary eicosanoids","volume":"53","author":"Sterz","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0225","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3390\/ijerph6071930","article-title":"Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999-2004","volume":"6","author":"Richter","year":"2009","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0230","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1080\/15287390600754953","article-title":"Urinary cadmium levels and tobacco smoke exposure in women age 20-69 years in the United States","volume":"70","author":"McElroy","year":"2007","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/bs.acc.2014.09.001_bb0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2288-10-19","article-title":"Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers","volume":"10","author":"Warner","year":"2010","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0240","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2009.02.055","article-title":"Effects of cigarette smoking on the human urinary proteome","volume":"381","author":"Airoldi","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.acc.2014.09.001_bb0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/1055-9965.EPI-09-1008","article-title":"210Pb: a predictive biomarker of retrospective cigarette smoke exposure","volume":"19","author":"Schayer","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0250","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1073\/pnas.74.8.3555","article-title":"Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine","volume":"74","author":"Yamasaki","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2014.09.001_bb0255","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.mrrev.2004.02.001","article-title":"Genotoxicity of tobacco smoke and tobacco smoke condensate: a review","volume":"567","author":"DeMarini","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/em.20277","article-title":"Mutagenic activity of overnight urine from healthy non-smoking subjects","volume":"48","author":"Pavanello","year":"2007","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/bs.acc.2014.09.001_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1382-6689(02)00125-4","article-title":"Effect of pH on mutagenicity of urine from smokers and nonsmokers","volume":"13","author":"Mohamadi","year":"2003","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0270","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/1055-9965.EPI-09-0819","article-title":"Methods used in internal industry clinical trials to assess tobacco risk reduction","volume":"18","author":"Rees","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0275","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/1556-4029.12130","article-title":"A new approach for the carbon monoxide (CO) exposure diagnosis: measurement of total CO in human blood versus carboxyhemoglobin (HbCO)","volume":"58","author":"Varlet","year":"2013","journal-title":"J. Forensic Sci."},{"key":"10.1016\/bs.acc.2014.09.001_bb0280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2005.11.003","article-title":"CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers","volume":"213","author":"Sarkar","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yrtph.2006.09.001","article-title":"Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany","volume":"47","author":"Scherer","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1078\/1438-4639-00324","article-title":"Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population","volume":"207","author":"Schettgen","year":"2004","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0295","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/pr100925p","article-title":"Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking","volume":"10","author":"Bortner","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0300","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/pr2006395","article-title":"Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD","volume":"11","author":"Ohlmeier","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0305","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1158\/0008-5472.CAN-09-1571","article-title":"Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/tx060232x","article-title":"Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation","volume":"20","author":"Chen","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0315","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/CS20120309","article-title":"Microparticles: biomarkers and beyond","volume":"124","author":"Burger","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/bs.acc.2014.09.001_bb0320","doi-asserted-by":"crossref","first-page":"e90314","DOI":"10.1371\/journal.pone.0090314","article-title":"The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers","volume":"9","author":"Mobarrez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2014.09.001_bb0325","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1164\/rccm.201012-2061OC","article-title":"Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers","volume":"184","author":"Gordon","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0330","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1160\/TH13-11-0977","article-title":"Smoking alters circulating plasma microvesicle pattern and microRNA signatures","volume":"112","author":"Badrnya","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/bs.acc.2014.09.001_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.00167.2009","article-title":"Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium","volume":"41","author":"Zhang","year":"2010","journal-title":"Physiol. Genomics"},{"key":"10.1016\/bs.acc.2014.09.001_bb0340","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/89.18.1366","article-title":"Molecular damage in the bronchial epithelium of current and former smokers","volume":"89","author":"Wistuba","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.acc.2014.09.001_bb0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1513\/pats.201011-066MS","article-title":"Transcriptomic studies of the airway field of injury associated with smoking-related lung disease","volume":"8","author":"Gower","year":"2011","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/bs.acc.2014.09.001_bb0350","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1378\/chest.125.5_suppl.115S","article-title":"Impact of cigarette smoke on the normal airway transcriptome","volume":"125","author":"Spira","year":"2004","journal-title":"Chest"},{"key":"10.1016\/bs.acc.2014.09.001_bb0355","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1073\/pnas.0806383106","article-title":"MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium","volume":"106","author":"Schembri","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2014.09.001_bb0360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1471-2164-9-259","article-title":"Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium","volume":"9","author":"Sridhar","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.acc.2014.09.001_bb0365","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1940-6207.CAPR-09-0192","article-title":"Effects of cigarette smoke on the human oral mucosal transcriptome","volume":"3","author":"Boyle","year":"2010","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/bs.acc.2014.09.001_bb0370","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2466-11-35","article-title":"Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation","volume":"11","author":"Bouloukaki","year":"2011","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0375","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2105\/AJPH.76.10.1245","article-title":"Some properties of saliva cotinine measurements in indicating exposure to tobacco smoking","volume":"76","author":"Di Giusto","year":"1986","journal-title":"Am. J. Public Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0380","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/clinchem\/32.6.979","article-title":"Quantification of cotinine in plasma and saliva by liquid chromatography","volume":"32","author":"Machacek","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2014.09.001_bb0385","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/FTD.0b013e318228ba39","article-title":"Oral fluid nicotine markers to assess smoking status and recency of use","volume":"33","author":"Scheidweiler","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/bs.acc.2014.09.001_bb0390","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ntr\/ntu021","article-title":"Detection limit of saliva cotinine values and statistical validity","volume":"16","author":"Kawada","year":"2014","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0395","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10544-013-9786-4","article-title":"Microfluidic immunoassay for rapid detection of cotinine in saliva","volume":"15","author":"Cheng","year":"2013","journal-title":"Biomed. Microdevices"},{"issue":"5","key":"10.1016\/bs.acc.2014.09.001_bb0400","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/add.12475","article-title":"Levels of saliva cotinine in electronic cigarette users","volume":"109","author":"Etter","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/bs.acc.2014.09.001_bb0405","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/NNR.0b013e3182456690","article-title":"Effect of passive smoking using maternal and neonatal salivary cotinine measurements","volume":"61","author":"Sachiyo","year":"2012","journal-title":"Nurs. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxlet.2013.11.032","article-title":"Noninvasive measurement of smoking-associated N(3)-ethyladenine and N(7)-ethylguanine in human salivary DNA by stable isotope dilution nanoflow liquid chromatography-nanospray ionization tandem mass spectrometry","volume":"225","author":"Chen","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/bs.acc.2014.09.001_bb0415","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxlet.2013.10.002","article-title":"Detection and simultaneous quantification of three smoking-related ethylthymidine adducts in human salivary DNA by liquid chromatography tandem mass spectrometry","volume":"224","author":"Chen","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/bs.acc.2014.09.001_bb0420","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.3390\/ijms11114488","article-title":"Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers","volume":"11","author":"Jessie","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.acc.2014.09.001_bb0425","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/pr401099r","article-title":"Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS method","volume":"13","author":"Mueller","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0430","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/092986712803414204","article-title":"Non-invasive biomarkers of lung inflammation in smoking subjects","volume":"19","author":"Malerba","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.acc.2014.09.001_bb0435","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.rmed.2009.06.002","article-title":"Biomarkers of lung damage associated with tobacco smoke in induced sputum","volume":"103","author":"Comandini","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0440","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1164\/rccm.201002-0304OC","article-title":"MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease","volume":"183","author":"Pottelberge","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0445","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/tc.11.3.176","article-title":"Hair as a biomarker for exposure to tobacco smoke","volume":"11","author":"Al-Delaimy","year":"2002","journal-title":"Tob. Control"},{"key":"10.1016\/bs.acc.2014.09.001_bb0450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/FTD.0b013e3181957a3b","article-title":"Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology","volume":"31","author":"Florescu","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/bs.acc.2014.09.001_bb0455","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jech.56.1.66","article-title":"Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine?","volume":"56","author":"Al-Delaimy","year":"2002","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0460","first-page":"1400","article-title":"Toenail nicotine levels as a biomarker of tobacco smoke exposure","volume":"11","author":"Al-Delaimy","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0465","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1158\/1055-9965.EPI-07-2695","article-title":"Measurement of tobacco smoke exposure: comparison of toenail nicotine biomarkers and self-reports","volume":"17","author":"Al-Delaimy","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0470","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1055-9965.EPI-07-0145","article-title":"Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine","volume":"16","author":"Stepanov","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0475","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-physiol-012110-142219","article-title":"Interaction of cigarette exposure and airway epithelial cell gene expression","volume":"73","author":"Brody","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0480","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hed.21705","article-title":"Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators","volume":"34","author":"Khariwala","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/bs.acc.2014.09.001_bb0485","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1373\/clinchem.2009.131797","article-title":"Plasma microRNAs as sensitive and specific biomarkers of tissue injury","volume":"55","author":"Laterza","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2014.09.001_bb0490","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0495","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mrfmmm.2011.04.005","article-title":"MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis","volume":"717","author":"Perdomo","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0500","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","article-title":"miRNA profiling of cancer","volume":"23","author":"Di Leva","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0505","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/bmm.12.50","article-title":"MicroRNAs as potential biomarkers of smoking-related diseases","volume":"6","author":"Banerjee","year":"2012","journal-title":"Biomark. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0510","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/ATVBAHA.112.300141","article-title":"MicroRNAs within the continuum of postgenomics biomarker discovery","volume":"33","author":"Mayr","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0515","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/bmm.13.9","article-title":"Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury","volume":"7","author":"Shi","year":"2013","journal-title":"Biomark. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0520","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/jnci\/djs027","article-title":"Clinical outcome prediction by microRNAs in human cancer: a systematic review","volume":"104","author":"Nair","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.acc.2014.09.001_bb0525","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0748233712452606","article-title":"Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis","volume":"30","author":"Yuchuan","year":"2012","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0530","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1378\/chest.12-1540","article-title":"The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases","volume":"142","author":"Doyle","year":"2012","journal-title":"Chest"},{"key":"10.1016\/bs.acc.2014.09.001_bb0535","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.seminoncol.2009.09.004","article-title":"Differential expression of biomarkers in men and women","volume":"36","author":"Planchard","year":"2009","journal-title":"Semin. Oncol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0540","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2288-13-143","article-title":"A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokers","volume":"13","author":"Kovalchik","year":"2013","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0545","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/bjoc.1999.0904","article-title":"Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy","volume":"82","author":"Kreuzer","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/bs.acc.2014.09.001_bb0550","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jnci\/88.3-4.183","article-title":"Differences in lung cancer risk between men and women: examination of the evidence","volume":"88","author":"Zang","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.acc.2014.09.001_bb0555","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/em.21777","article-title":"Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk","volume":"54","author":"Wild","year":"2013","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/bs.acc.2014.09.001_bb0560","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.euroneuro.2007.12.005","article-title":"Global DNA methylation is influenced by smoking behaviour","volume":"18","author":"Hillemacher","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0565","doi-asserted-by":"crossref","first-page":"e7959","DOI":"10.1371\/journal.pone.0007959","article-title":"Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation","volume":"4","author":"Launay","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2014.09.001_bb0570","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1289\/ehp.1205412","article-title":"450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy","volume":"120","author":"Joubert","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/bs.acc.2014.09.001_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(97)00648-X","article-title":"Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996","volume":"17","author":"Boyle","year":"1997","journal-title":"Lung Cancer"},{"key":"10.1016\/bs.acc.2014.09.001_bb0580","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0031-1278254","article-title":"Cigarette smoke and adverse health effects: an overview of research trends and future needs","volume":"16","author":"Saha","year":"2007","journal-title":"Int. J. Angiol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0585","first-page":"iii","article-title":"NTP 12th report on carcinogens","volume":"12","author":"Health and Human Services","year":"2011","journal-title":"Rep. Carcinog."},{"key":"10.1016\/bs.acc.2014.09.001_bb0590","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1940-6207.CAPR-11-0212","article-title":"Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq","volume":"4","author":"Beane","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/bs.acc.2014.09.001_bb0595","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.pupt.2010.05.006","article-title":"Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review","volume":"23","author":"Comandini","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/bs.acc.2014.09.001_bb0600","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature06802","article-title":"The search for new cardiovascular biomarkers","volume":"451","author":"Gerszten","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2014.09.001_bb0605","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11883-012-0244-1","article-title":"Atherosclerosis, inflammation, genetics, and stem cells: 2012 update","volume":"14","author":"Goldschmidt-Clermont","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/bs.acc.2014.09.001_bb0610","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/1354750X.2011.608855","article-title":"Proteomic profiling of human respiratory epithelia by iTRAQ reveals biomarkers of exposure and harm by tobacco smoke components","volume":"16","author":"Sexton","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/bs.acc.2014.09.001_bb0615","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/10408444.2012.725244","article-title":"Genomic impact of cigarette smoke, with application to three smoking-related diseases","volume":"42","author":"Talikka","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0620","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1158\/1078-0432.CCR-09-1694","article-title":"Smoking-related gene expression in laser capture-microdissected human lung","volume":"15","author":"Tan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0625","article-title":"DNA methylation is globally disrupted and associated with expression changes in COPD small airways","author":"Vucic","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0630","doi-asserted-by":"crossref","first-page":"e11934","DOI":"10.1371\/journal.pone.0011934","article-title":"Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2014.09.001_bb0635","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mrrev.2012.08.002","article-title":"Harnessing genomics to identify environmental determinants of heritable disease","volume":"752","author":"Yauk","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0640","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1513\/pats.200807-074TH","article-title":"Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management","volume":"5","author":"Zeskind","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/bs.acc.2014.09.001_bb0645","doi-asserted-by":"crossref","first-page":"e72669","DOI":"10.1371\/journal.pone.0072669","article-title":"High correlation of the response of upper and lower lobe small airway epithelium to smoking","volume":"8","author":"Harvey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.acc.2014.09.001_bb0650","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1165\/rcmb.2002-0183RC","article-title":"Gene expression in lung adenocarcinomas of smokers and nonsmokers","volume":"29","author":"Powell","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0655","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1940-6207.CAPR-08-0058","article-title":"Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs","volume":"1","author":"Bhutani","year":"2008","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/bs.acc.2014.09.001_bb0660","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1158\/0008-5472.CAN-04-1771","article-title":"Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells","volume":"64","author":"Spivack","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0665","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1186\/gb-2007-8-9-r201","article-title":"Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression","volume":"8","author":"Beane","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0670","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1073\/pnas.0401422101","article-title":"Effects of cigarette smoke on the human airway epithelial cell transcriptome","volume":"101","author":"Spira","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2014.09.001_bb0675","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/1940-6207.CAPR-07-0017","article-title":"Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers","volume":"1","author":"Zhang","year":"2008","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/bs.acc.2014.09.001_bb0680","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2164-8-297","article-title":"Effect of active smoking on the human bronchial epithelium transcriptome","volume":"8","author":"Chari","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.acc.2014.09.001_bb0685","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/jnci\/94.19.1435","article-title":"Tobacco smoking, harm reduction, and biomarkers","volume":"94","author":"Shields","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.acc.2014.09.001_bb0690","doi-asserted-by":"crossref","first-page":"A700","DOI":"10.1289\/ehp.114-a700","article-title":"Signs of the times: biomarkers in perspective","volume":"114","author":"Schmidt","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/bs.acc.2014.09.001_bb0695","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.2012.06531.x","article-title":"Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease","volume":"1259","author":"Moretto","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2014.09.001_bb0700","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.jprot.2011.05.039","article-title":"Proteomic profiling of acrolein adducts in human lung epithelial cells","volume":"74","author":"Spiess","year":"2011","journal-title":"J. Proteomics"},{"key":"10.1016\/bs.acc.2014.09.001_bb0705","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1165\/rcmb.2006-0339OC","article-title":"Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production","volume":"38","author":"Deshmukh","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0710","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1164\/rccm.200903-0328OC","article-title":"Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production","volume":"180","author":"Deshmukh","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0715","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/tx8001934","article-title":"Genome-wide transcriptional responses to acrolein","volume":"21","author":"Thompson","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0720","first-page":"110","article-title":"Interaction between tobacco smoking and occupational exposures in the causation of lung cancer","volume":"28","author":"Steenland","year":"1986","journal-title":"J. Occup. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0725","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0003-4878(00)00060-0","article-title":"The interaction of asbestos and smoking in lung cancer","volume":"45","author":"Liddell","year":"2001","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/bs.acc.2014.09.001_bb0730","first-page":"157","article-title":"Radon and lung cancer","volume":"10","author":"Sethi","year":"2012","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0735","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2105\/AJPH.2012.300926","article-title":"Radon, smoking, and lung cancer: the need to refocus radon control policy","volume":"103","author":"Lantz","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0740","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10147-010-0056-7","article-title":"Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention","volume":"15","author":"Morita","year":"2010","journal-title":"Int. J. Clin. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/bs.acc.2014.09.001_bb0745","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.2188\/jea.15.S212","article-title":"Smoking, alcohol drinking and esophageal cancer: findings from the JACC Study","volume":"15","author":"Sakata","year":"2005","journal-title":"J. Epidemiol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0750","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<657::AID-IJC7>3.0.CO;2-C","article-title":"Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women","volume":"82","author":"Castellsague","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.acc.2014.09.001_bb0755","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10147-010-0057-6","article-title":"Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis","volume":"15","author":"Toh","year":"2010","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0760","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1037\/0278-6133.4.4.337","article-title":"The synergistic effect of smoking and serum cholesterol on coronary heart disease","volume":"4","author":"Perkins","year":"1985","journal-title":"Health Psychol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0765","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/HJH.0b013e328359aa1f","article-title":"Does cigarette smoking exacerbate the effect of blood pressure on the risk of cardiovascular and all-cause mortality among hypertensive patients?","volume":"30","author":"Ge","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/bs.acc.2014.09.001_bb0770","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature06885","article-title":"A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25","volume":"452","author":"Hung","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2014.09.001_bb0775","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature06846","article-title":"A variant associated with nicotine dependence, lung cancer and peripheral arterial disease","volume":"452","author":"Thorgeirsson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.acc.2014.09.001_bb0780","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/aje\/kwr467","article-title":"Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction","volume":"175","author":"VanderWeele","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0785","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tips.2009.10.004","article-title":"Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25","volume":"31","author":"Bierut","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/bs.acc.2014.09.001_bb0790","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1158\/1055-9965.EPI-08-0585","article-title":"Nicotinic receptor gene variants influence susceptibility to heavy smoking","volume":"17","author":"Stevens","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-009-0748-0","article-title":"Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment","volume":"127","author":"Rodriguez-Antona","year":"2010","journal-title":"Hum. Genet."},{"key":"10.1016\/bs.acc.2014.09.001_bb0800","first-page":"3","article-title":"Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers","volume":"9","author":"Bartsch","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0805","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","article-title":"Tobacco smoke carcinogens and lung cancer","volume":"91","author":"Hecht","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/bs.acc.2014.09.001_bb0810","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0378-4274(99)00235-0","article-title":"Epoxide hydrolase\u2014polymorphism and role in toxicology","volume":"112\u2013113","author":"Omiecinski","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/bs.acc.2014.09.001_bb0815","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1289\/ehp.6065","article-title":"The role of genetic polymorphisms in environmental health","volume":"111","author":"Kelada","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/bs.acc.2014.09.001_bb0820","first-page":"461","article-title":"Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction","volume":"9","author":"Marcus","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/bs.acc.2014.09.001_bb0825","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00008571-200003000-00003","article-title":"NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population","volume":"10","author":"Marcus","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/bs.acc.2014.09.001_bb0830","first-page":"5","article-title":"Biomarkers in oncology drug development","volume":"7","author":"Boulton","year":"2010","journal-title":"Regul. Rapport."},{"key":"10.1016\/bs.acc.2014.09.001_bb0835","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/17520363.2.3.305","article-title":"Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective","volume":"2","author":"Amur","year":"2008","journal-title":"Biomark. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0840","unstructured":"IARC Working Group on Methods for Evaluating Tobacco Control Policies, Methods for Evaluating Tobacco Control Policies, Tobacco Control Vol 12, International Agency for Research on Cancer, 2008, Lyon."},{"key":"10.1016\/bs.acc.2014.09.001_bb0845","first-page":"112","article-title":"The scientific basis of tobacco product regulation","author":"WHO Study Group on Tobacco Product Regulation","year":"2007"},{"key":"10.1016\/bs.acc.2014.09.001_bb0850","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14622200500266015","article-title":"Methods to assess potential reduced exposure products","volume":"7","author":"Hatsukami","year":"2005","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0855","first-page":"289","article-title":"The scientific basis of tobacco product regulation","author":"WHO Study Group on Tobacco Product Regulation","year":"2008"},{"key":"10.1016\/bs.acc.2014.09.001_bb0860","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/1354750X.2013.777116","article-title":"Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective","volume":"18","author":"Lowe","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/bs.acc.2014.09.001_bb0865","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/mutage\/geq071","article-title":"Cytokinesis-blocked micronucleus assay and cancer risk assessment","volume":"26","author":"El-Zein","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/bs.acc.2014.09.001_bb0870","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijheh.2007.01.024","article-title":"Human biomonitoring: state of the art","volume":"210","author":"Angerer","year":"2007","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0875","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1289\/ehp.9298167","article-title":"Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research","volume":"98","author":"Wogan","year":"1992","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/bs.acc.2014.09.001_bb0880","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cbi.2010.10.010","article-title":"1,3-Butadiene: biomarkers and application to risk assessment","volume":"192","author":"Swenberg","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/bs.acc.2014.09.001_bb0885","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.yrtph.2012.07.008","article-title":"Cadmium exposure and tobacco consumption: biomarkers and risk assessment","volume":"64","author":"Marano","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0890","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yrtph.2012.07.007","article-title":"Arsenic exposure and tobacco consumption: biomarkers and risk assessment","volume":"64","author":"Marano","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0895","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2105\/AJPH.2004.055012","article-title":"Early evidence on the effectiveness of clean indoor air legislation in New York State","volume":"96","author":"Abrams","year":"2006","journal-title":"Am. J. Public Health"},{"key":"10.1016\/bs.acc.2014.09.001_bb0900","series-title":"Environmental and Biological Assessment of Environmental Tobacco Smoke Exposure Among Casino Dealers","first-page":"39","author":"Achutan","year":"2009"},{"key":"10.1016\/bs.acc.2014.09.001_bb0905","series-title":"Laramie, Wyoming Bar Patron Cotinine Study","first-page":"14","author":"Repace","year":"2005"},{"key":"10.1016\/bs.acc.2014.09.001_bb0910","unstructured":"M. Engelen, M. Farrelly, A. Hyland, The Health and Economic Impact of New York's Clean Indoor Air Act. <http:\/\/www.health.ny.gov\/prevention\/tobacco_control\/docs\/ciaa_impact_report.pdf>, 2006 (December 5, 2013)."},{"key":"10.1016\/bs.acc.2014.09.001_bb0915","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0887-2333(95)00087-9","article-title":"Validation: a highly charged concept","volume":"9","author":"Koeter","year":"1995","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/bs.acc.2014.09.001_bb0920","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0887-2333(01)00070-4","article-title":"Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice","volume":"15","author":"Spielmann","year":"2001","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/bs.acc.2014.09.001_bb0925","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0887-2333(99)00067-3","article-title":"The validation and acceptance of alternatives to animal testing","volume":"13","author":"Balls","year":"1999","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/bs.acc.2014.09.001_bb0930","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrd2174","article-title":"A cost-effectiveness approach to the qualification and acceptance of biomarkers","volume":"5","author":"Williams","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.acc.2014.09.001_bb0935","series-title":"Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease","year":"2010"},{"key":"10.1016\/bs.acc.2014.09.001_bb0940","series-title":"Committee on Scientific Standards for Studies on Modified Risk Tobacco Products, I.o. Medicine, Scientific Standards for Studies on Modified Risk Tobacco Products","year":"2012"},{"key":"10.1016\/bs.acc.2014.09.001_bb0945","series-title":"Quality Assurance","author":"Wikipedia","year":"2014"},{"key":"10.1016\/bs.acc.2014.09.001_bb0950","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/1354750X.2013.821523","article-title":"Urinary biomarkers of smokers\u2019 exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach","volume":"18","author":"Gregg","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/bs.acc.2014.09.001_bb0955","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1158\/1078-0432.CCR-07-4535","article-title":"Validation of analytic methods for biomarkers used in drug development","volume":"14","author":"Chau","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb0960","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjp.0707441","article-title":"Biomarker method validation in anticancer drug development","volume":"153","author":"Cummings","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0965","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.pharmtox.48.113006.094611","article-title":"Strategic approach to fit-for-purpose biomarkers in drug development","volume":"48","author":"Wagner","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0970","doi-asserted-by":"crossref","first-page":"47ps44","DOI":"10.1126\/scitranslmed.3001040","article-title":"Translational medicine and the value of biomarker qualification","volume":"2","author":"Goodsaid","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb0975","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nbt.1634","article-title":"Towards consensus practices to qualify safety biomarkers for use in early drug development","volume":"28","author":"Sistare","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/bs.acc.2014.09.001_bb0980","series-title":"Critical Path Opportunities List","author":"U.S. FDA","year":"2006"},{"key":"10.1016\/bs.acc.2014.09.001_bb0985","series-title":"Qualify","author":"Merriam-Webster.com","year":"2013"},{"key":"10.1016\/bs.acc.2014.09.001_bb0990","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.clpt.6100017","article-title":"Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs","volume":"81","author":"Wagner","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/bs.acc.2014.09.001_bb0995","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.clpt.6100451","article-title":"A prototypical process for creating evidentiary standards for biomarkers and diagnostics","volume":"83","author":"Altar","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/bs.acc.2014.09.001_bb1000","series-title":"Guidance for Industry: Qualification Process for Drug Development Tools","author":"U.S. FDA","year":"2010"},{"key":"10.1016\/bs.acc.2014.09.001_bb1005","series-title":"Biomarker qualification context of use","author":"U.S. FDA","year":"2011"},{"key":"10.1016\/bs.acc.2014.09.001_bb1010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nbt0510-432","article-title":"Research at the interface of industry, academia and regulatory science","volume":"28","author":"Mattes","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/bs.acc.2014.09.001_bb1015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2014.09.001_bb1020","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/sim.3975","article-title":"Bayesian estimation of the receiver operating characteristic curve for a diagnostic test with a limit of detection in the absence of a gold standard","volume":"29","author":"Jafarzadeh","year":"2010","journal-title":"Stat. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb1025","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/bs.acc.2014.09.001_bb1030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1373\/clinchem.2007.096529","article-title":"Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve","volume":"54","author":"Cook","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2014.09.001_bb1035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.2008.061010","article-title":"Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research","volume":"62","author":"Soreide","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/bs.acc.2014.09.001_bb1040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3414\/ME0583","article-title":"A simple modeling-free method provides accurate estimates of sensitivity and specificity of longitudinal disease biomarkers","volume":"48","author":"Subtil","year":"2009","journal-title":"Methods Inf. Med."},{"key":"10.1016\/bs.acc.2014.09.001_bb1045","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1158\/1078-0432.CCR-07-4534","article-title":"Validation of biomarker-based risk prediction models","volume":"14","author":"Taylor","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.acc.2014.09.001_bb1050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med. Inform. Decis. Mak."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006524231400002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S006524231400002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:30:46Z","timestamp":1758742246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S006524231400002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9780128022672"],"references-count":210,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2014.09.001","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}